Mednax Inc (MD)
Activity ratios
Short-term
Turnover ratios
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Inventory turnover | — | 116.31 | — | — | — |
| Receivables turnover | — | — | — | — | — |
| Payables turnover | — | — | — | — | — |
| Working capital turnover | 9.80 | 21.11 | — | 5.51 | 1.54 |
Based on the data provided for Mednax Inc's activity ratios, we can make the following observations:
1. Inventory Turnover: The company did not provide any specific data for inventory turnover for the years 2020, 2021, and 2022. However, in 2023, the inventory turnover was 116.31, indicating that the company efficiently managed its inventory by selling and replenishing it multiple times during that period.
2. Receivables Turnover: There is no data available for receivables turnover for any of the years indicated, suggesting that we cannot analyze how quickly the company collected its accounts receivable during those years.
3. Payables Turnover: Similar to receivables turnover, there is no information provided for payables turnover, making it difficult to assess how quickly the company paid its suppliers during the specified years.
4. Working Capital Turnover: In 2020, the working capital turnover was 1.54, which increased significantly to 5.51 in 2021, indicating a more efficient use of working capital. However, there is no data available for 2022, and in 2023, the working capital turnover surged to 21.11, suggesting a substantial increase in the company's ability to generate revenue relative to its working capital. In 2024, the working capital turnover slightly decreased to 9.80 but remained at a relatively high level compared to the earlier years.
Overall, while the specific data for receivables turnover and payables turnover are not provided, the analysis of inventory turnover and working capital turnover reflects Mednax Inc's effectiveness in managing its inventory and working capital to drive business operations and generate revenue efficiently.
Average number of days
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | — | 3.14 | — | — | — |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
Based on the provided data for Mednax Inc, it appears that the company's activity ratios are as follows:
1. Days of Inventory on Hand (DOH):
- As of December 31, 2020, the days of inventory on hand were not provided.
- As of December 31, 2021, the days of inventory on hand were not provided.
- As of December 31, 2022, the days of inventory on hand were not provided.
- As of December 31, 2023, the company had 3.14 days of inventory on hand.
- As of December 31, 2024, the days of inventory on hand were not provided.
2. Days of Sales Outstanding (DSO):
- Data for days of sales outstanding was not provided for any of the years from 2020 to 2024.
3. Number of Days of Payables:
- Data for the number of days of payables was not provided for any of the years from 2020 to 2024.
Overall, based on the limited data provided, it is observed that Mednax Inc had a very low level of inventory on hand as of December 31, 2023, indicating efficient inventory management. However, no information was available for days of sales outstanding and the number of days of payables, which are essential for a comprehensive analysis of the company's activity ratios.
Long-term
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
|---|---|---|---|---|---|
| Fixed asset turnover | — | — | 26.91 | 27.24 | 22.76 |
| Total asset turnover | 0.94 | 0.90 | 0.84 | 0.70 | 0.52 |
The fixed asset turnover ratio measures a company's ability to generate sales revenue relative to its investment in fixed assets. In the case of Mednax Inc, the fixed asset turnover ratio has shown an increasing trend over the years, from 22.76 in 2020 to 27.24 in 2021 and 26.91 in 2022. However, the data is not available for 2023 and 2024.
This indicates that the company is becoming more efficient in utilizing its fixed assets to generate sales revenue, which is a positive sign as higher ratios suggest better asset utilization and productivity.
Total asset turnover ratio, on the other hand, measures a company's ability to generate sales relative to its total assets. In the case of Mednax Inc, the total asset turnover ratio has also been increasing steadily over the years, from 0.52 in 2020 to 0.70 in 2021, 0.84 in 2022, 0.90 in 2023, and 0.94 in 2024.
This indicates that the company is effectively using its total assets to generate sales, reflecting improved efficiency and productivity over the years. Overall, the increasing trend in both fixed asset turnover and total asset turnover ratios suggests that Mednax Inc is managing its assets efficiently and effectively in generating sales revenue.